153 related articles for article (PubMed ID: 27307760)
21. Prevalence of protective haplotypes of the
Favela-Mendoza AF; Rodríguez-Rodríguez BG; Rojas-Prado E; Chávez-Arreguin M; Aguilar-Velázquez JA; Martínez-Cortés G; Rangel-Villalobos H
Per Med; 2021 Sep; 18(6):533-540. PubMed ID: 34674552
[TBL] [Abstract][Full Text] [Related]
22. The SLCO1B1 c.521T>C polymorphism is associated with dose decrease or switching during statin therapy in the Rotterdam Study.
de Keyser CE; Peters BJ; Becker ML; Visser LE; Uitterlinden AG; Klungel OH; Verstuyft C; Hofman A; Maitland-van der Zee AH; Stricker BH
Pharmacogenet Genomics; 2014 Jan; 24(1):43-51. PubMed ID: 24263182
[TBL] [Abstract][Full Text] [Related]
23. Statin-associated muscle symptoms and SLCO1B1 rs4149056 genotype in patients with familial hypercholesterolemia.
Khine H; Yuet WC; Adams-Huet B; Ahmad Z
Am Heart J; 2016 Sep; 179():1-9. PubMed ID: 27595674
[TBL] [Abstract][Full Text] [Related]
24. Predictive Value of
Jansen ME; Rigter T; Fleur TMC; Souverein PC; Verschuren WMM; Vijverberg SJ; Swen JJ; Rodenburg W; Cornel MC
Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833383
[TBL] [Abstract][Full Text] [Related]
25. A systematic review and meta-analysis of genotype-based and individualized data analysis of SLCO1B1 gene and statin-induced myopathy.
Turongkaravee S; Jittikoon J; Lukkunaprasit T; Sangroongruangsri S; Chaikledkaew U; Thakkinstian A
Pharmacogenomics J; 2021 Jun; 21(3):296-307. PubMed ID: 33608664
[TBL] [Abstract][Full Text] [Related]
26. Comparison of
Sychev DA; Shuev GN; Suleymanov SS; Ryzhikova KA; Mirzaev KB; Grishina EA; Snalina NE; Sozaeva ZA; Grabuzdov AM; Matsneva IA
Pharmgenomics Pers Med; 2017; 10():93-99. PubMed ID: 28435307
[TBL] [Abstract][Full Text] [Related]
27. A Cost-Consequence Analysis of Preemptive
Brunette CA; Dong OM; Vassy JL; Danowski ME; Alexander N; Antwi AA; Christensen KD
J Pers Med; 2021 Oct; 11(11):. PubMed ID: 34834475
[TBL] [Abstract][Full Text] [Related]
28. Possible gene-gender interaction between the SLCO1B1 polymorphism and statin treatment efficacy.
Hubacek JA; Dlouha D; Adámkova V; Lanska V; Ceska R; Vrablik M
Neuro Endocrinol Lett; 2012; 33 Suppl 2():22-5. PubMed ID: 23183505
[TBL] [Abstract][Full Text] [Related]
29. SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid.
Pasanen MK; Neuvonen M; Neuvonen PJ; Niemi M
Pharmacogenet Genomics; 2006 Dec; 16(12):873-9. PubMed ID: 17108811
[TBL] [Abstract][Full Text] [Related]
30. Association between rs4149056 variant in
Al-Salameh A; Danchin N; Verstuyft C; Kotti S; Puymirat E; Ferrières J; Schiele F; Coste P; Lemesle G; Cayla G; Becquemont L; Simon T
Pharmacogenomics; 2020 Feb; 21(3):163-172. PubMed ID: 31967516
[TBL] [Abstract][Full Text] [Related]
31. Pharmacogenetic analysis of inter-ethnic variability in the uptake transporter SLCO1B1 gene in Colombian, Mozambican, and Portuguese populations.
Nega MH; Berhe DF; Ribeiro V
BMC Med Genomics; 2023 Sep; 16(1):207. PubMed ID: 37658350
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of serum SLCO1B1 levels and genetic variants of SLCO1B1 rs4149056 and rs2306283 in patients with early and exudative age-related macular degeneration.
Liutkeviciene R; Vilkeviciute A; Slavinskaite A; Petrauskaite A; Tatarunas V; Kriauciuniene L
Gene; 2018 Nov; 676():139-145. PubMed ID: 30010042
[TBL] [Abstract][Full Text] [Related]
33. Effects of
Fernandes Silva L; Ravi R; Vangipurapu J; Oravilahti A; Laakso M
Metabolites; 2022 Nov; 12(12):. PubMed ID: 36557197
[TBL] [Abstract][Full Text] [Related]
34. Pharmacogenetic testing by polymorphic markers 681G>A and 636G>A CYP2C19 gene in patients with acute coronary syndrome and gastric ulcer in the Republic of Sakha (Yakutia).
Fedorinov DS; Mirzaev KB; Ivashchenko DV; Temirbulatov II; Sychev DA; Maksimova NR; Chertovskih JV; Popova NV; Tayurskaya KS; Rudykh ZA
Drug Metab Pers Ther; 2018 Jun; 33(2):91-98. PubMed ID: 29738309
[TBL] [Abstract][Full Text] [Related]
35. Marked differences in frequencies of statin therapy relevant SLCO1B1 variants and haplotypes between Roma and Hungarian populations.
Nagy A; Sipeky C; Szalai R; Melegh BI; Matyas P; Ganczer A; Toth K; Melegh B
BMC Genet; 2015 Sep; 16():108. PubMed ID: 26334733
[TBL] [Abstract][Full Text] [Related]
36. Statin treatment effectiveness and the SLCO1B1*5 reduced function genotype: Long-term outcomes in women and men.
Türkmen D; Masoli JAH; Kuo CL; Bowden J; Melzer D; Pilling LC
Br J Clin Pharmacol; 2022 Jul; 88(7):3230-3240. PubMed ID: 35083771
[TBL] [Abstract][Full Text] [Related]
37. Pharmacogenetics of Statin-Induced Myopathy: A Focused Review of the Clinical Translation of Pharmacokinetic Genetic Variants.
Talameh JA; Kitzmiller JP
J Pharmacogenomics Pharmacoproteomics; 2014 Apr; 5(2):. PubMed ID: 25221728
[TBL] [Abstract][Full Text] [Related]
38. Association between SLCO1B1 -521T>C and -388A>G polymorphisms and risk of statin-induced adverse drug reactions: A meta-analysis.
Jiang J; Tang Q; Feng J; Dai R; Wang Y; Yang Y; Tang X; Deng C; Zeng H; Zhao Y; Zhang F
Springerplus; 2016; 5(1):1368. PubMed ID: 27606156
[TBL] [Abstract][Full Text] [Related]
39. Impact of SLCO1B1 521T > C variant on leucovorin rescue and risk of relapse in childhood acute lymphoblastic leukemia treated with high-dose methotrexate.
Zhang HN; He XL; Wang C; Wang Y; Chen YJ; Li JX; Niu CH; Gao P
Pediatr Blood Cancer; 2014 Dec; 61(12):2203-7. PubMed ID: 25130190
[TBL] [Abstract][Full Text] [Related]
40. Association of SLCO1B1 and ABCB1 Genetic Variants with Atorvastatin-induced Myopathy in Patients with Acute Ischemic Stroke.
Zhang L; Lv H; Zhang Q; Wang D; Kang X; Zhang G; Li X
Curr Pharm Des; 2019; 25(14):1663-1670. PubMed ID: 31298164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
